ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 979,31
0,52%
Dow Jones
40 813,57
-1,30%
DAX
22 631,00
0,44%
Brent Oil
70,495
0,82%
Bitcoin
82 585,65
1,91%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Molecular Partners Ag (0QXX)

  7. Molecular Partners Ag (0QXX) Actualités

0QXX

Molecular Partners (0QXX)

Molecular Partners Ag
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0QXX
DateHeureSourceTitreSymboleSociété
06/03/202522h00UK RegulatoryMolecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024LSE:0QXXMolecular Partners Ag
28/02/202507h00UK RegulatoryMolecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference CallLSE:0QXXMolecular Partners Ag
12/01/202519h00UK RegulatoryMolecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancerLSE:0QXXMolecular Partners Ag
12/01/202519h00UK RegulatoryMolecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare ConferenceLSE:0QXXMolecular Partners Ag
17/12/202422h00UK RegulatoryMolecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in JanuaryLSE:0QXXMolecular Partners Ag
08/12/202418h00UK RegulatoryMolecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024LSE:0QXXMolecular Partners Ag
07/11/202422h00UK RegulatoryMolecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024LSE:0QXXMolecular Partners Ag
05/11/202422h00UK RegulatoryMolecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and ExpositionLSE:0QXXMolecular Partners Ag
31/10/202421h00UK RegulatoryMolecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-goingLSE:0QXXMolecular Partners Ag
25/10/202407h00UK RegulatoryMolecular Partners Announces Pricing of $20 Million Underwritten OfferingLSE:0QXXMolecular Partners Ag
22/10/202407h00UK RegulatoryMolecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin TherapeuticsLSE:0QXXMolecular Partners Ag
22/10/202407h00UK RegulatoryMolecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024LSE:0QXXMolecular Partners Ag
04/10/202407h00UK RegulatoryMolecular Partners Announces upcoming poster presentations at the 2024 SITC Annual MeetingLSE:0QXXMolecular Partners Ag
27/09/202407h00UK RegulatoryMolecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024LSE:0QXXMolecular Partners Ag
26/08/202422h00UK RegulatoryMolecular Partners Reports H1 2024 Corporate Highlights and FinancialsLSE:0QXXMolecular Partners Ag
14/06/202407h00UK RegulatoryMolecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024LSE:0QXXMolecular Partners Ag
11/06/202407h00UK RegulatoryMolecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024LSE:0QXXMolecular Partners Ag
19/04/202417h12UK RegulatoryLife Science Cares Launches in SwitzerlandLSE:0QXXMolecular Partners Ag
 Showing the most relevant articles for your search:LSE:0QXX

Dernières Valeurs Consultées

TG
A3K9SJ
Asian Development Bank
NASDAQ
CCWNX
Ci Doubleline Total Retu...
NASDAQ
CJRBX
Counsel Retirement Prese...
NASDAQ
FEAQX
Bmo Retirement Balanced ...
NASDAQ
FEJGX
Bmo Sustainable Balanced...
NASDAQ
DDZSX
Marquis Institutional Gl...
NASDAQ
DAGDX
Chorus Ii Moderate Low V...
UNSW3
PAXETH
PayperEx
NASDAQ
PDAOX
Pgim Target Date 2070 Fu...
NASDAQ
CGXGX
Ci Synergy American Fund...
POLO
LDOUSDT
Lido DAO Token
NASDAQ
CEFPX
Ci Global Shortterm Bond...
NASDAQ
FEFGX
Bmo Selecttrust Equity G...
NASDAQ
CCHDX
Ci Canadian Income and G...
NASDAQ
CJQZX
Counsel Retirement Prese...
NASDAQ
FAXOX
Agf American Growth Fund...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces